Linical is a public, mid-sized Contract Research Organization (CRO) headquartered in Japan with a significant presence across North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, infectious disease, and CNS. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team. At Linical, we are the trusted, global CRO to deliver innovative solutions for even the most complex industry challenges. We provide our clients with the personal attention, flexibility, and reach needed for a continually evolving pharmaceutical and biotech market. We believe in supporting clients throughout their unique clinical development journey, with a shared goal of bringing promising new therapies to patients all over the world. Linical’s vision is to be the CRO of choice amongst the global, mid-sized CRO market. We will achieve this by continuing to expand our current geographical reach into additional parts of the world, enabling us to thoughtfully partner with our clients anywhere their clinical development endeavors take them. While strategically growing our business, we are committed to maintaining the personal, attentive service our clients, employees, and patients deserve.